Testosterone Replacement Therapy and the Risk of Prostate Cancer. Is There a Link?

A. Barqawi; E. D. Crawford

Disclosures

Int J Impot Res. 2006;18(4):323-328. 

In This Article

Conclusion

In spite of the theoretical increase in prostate cancer risk following TRT, there is currently no evidence that testosterone administration can initiate or promote a de novo or pre-existing prostatic malignancy in hypogonadal men.[40] In fact, there are strong indications that normal testosterone levels play a protective role in the natural history of prostate cancer. Many studies have demonstrated that a low testosterone level prior to treatment is an independent predictor of a more aggressive, high-grade cancer,[20] an increased likelihood of extraprostatic disease at the time of diagnosis,[41] and a decreased likelihood of a favorable treatment response.[42] Nevertheless, most of these trials are limited in sample size and duration of therapy. Therefore, until the true risk of TRT has been established in long-term studies, it is crucial to carefully screen and closely monitor these men for occult prostate cancer.


CLICK HERE for subscription information about this journal.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....